All News

The recurrence rate following thermal ablation of renal cortical tumors is 6%. About half of recurrences can be managed successfully with salvage ablative procedures, but 20% require extirpative surgery, according to retrospective findings obtained from databases from 10 U.S. centers.

Among men treated with curative radiation therapy and neoadjuvant, adjuvant, or concurrent ADT, about one-fourth fail to achieve or maintain true castrate levels of testosterone suppression, according to a study from the University of British Columbia, Vancouver.

A study comparing postoperative pain between robot-assisted laparoscopic radical prostatectomy (RALP) and laparoscopic radical prostatectomy (LRP) appears to favor the robotic technique.

While Agent Orange, an herbicide used during the Vietnam War, has been previously linked to a variety of types of cancers in Vietnam veterans, new data from the Veterans Affairs Medical Center in Shreveport, LA, indicates that there may be a connection between veterans? in-country exposure and subsequent development of renal cancer.

Results of a retrospective study investigating men with clinically localized prostate cancer who underwent radical retropubic prostatectomy with bilateral pelvic lymph node dissection (PLND) show a higher than expected incidence of LN metastases, but men with nodal involvement had excellent 10-year clinical recurrence-free survival.

Among men receiving early androgen deprivation therapy (ADT) for biochemical recurrence after radical prostatectomy, obesity appears to be a significant risk factor for poorer prognosis, according to the results of a retrospective study presented yesterday.

A population-based study evaluating 25-year trends in renal stone findings among children reported a 4% per year increase in incidence, driven largely by consistently escalating renal stone rates in the 12- to 17-year age group, Mayo Clinic researchers reported yesterday.

Urologists attending localized prostate cancer sessions at the upcoming AUA annual meeting in Washington will hear more about the ongoing debate on open versus minimally invasive radical prostatectomy, the use of 5-alpha-reductase inhibitors (5-ARIs) in men on active surveillance, and updates on treatment approaches such as high-intensity focused ultrasound.